Literature DB >> 26250581

Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy.

Hideki Nakasone1, Mats Remberger2, Lu Tian3, Petter Brodin4, Bita Sahaf5, Fang Wu5, Jonas Mattsson2, Robert Lowsky5, Robert Negrin5, David B Miklos5, Everett Meyer6.   

Abstract

Sex-mismatched hematopoietic cell transplantation is linked to increased graft-versus-host disease and mortality in myeloablative conditioning. Here we evaluated outcomes of 1,041 adult transplant recipients at two centers between 2006 and 2013 and investigated how the effect of sex-mismatching differed in myeloablative, reduced-intensity, and non-myeloablative total lymphoid irradiation with anti-thymocyte globulin conditioning. Among patients who underwent myeloablative conditioning, male recipients with female donors had increased chronic graft-versus-host disease (hazard ratio 1.83, P<0.01), increased non-relapse mortality (hazard ratio 1.84, P=0.022) and inferior overall survival (hazard ratio 1.59, P=0.018). In contrast, among patients who received reduced-intensity conditioning, male recipients with female donors had increased acute graft-versus-host disease (hazard ratio 1.96, P<0.01) but no difference in non-relapse mortality or overall survival. Among the patients who underwent total lymphoid irradiation with anti-thymocyte globulin, male recipients with female donors showed no increase in graft-versus-host disease or non-relapse mortality. Notably, only in the cohort receiving total lymphoid irradiation with anti-thymocyte globulin were male recipients with female donors significantly associated with reduced relapse (hazard ratio 0.64, P<0.01), and allo-antibody responses against H-Y antigens were predictive of reduced relapse. In the cohort given total lymphoid irradiation with anti-thymocyte globulin, the graft-versus-leukemia effect resulted in superior overall survival in recipients of sex-mismatched grafts (HR 0.69, P=0.037). In addition, only in the cohort treated with total lymphoid irradiation with anti-thymocyte globulin were female recipients with male donors associated with reduced relapse (hazard ratio 0.59, P<0.01) and superior survival (hazard ratio 0.61, P=0.014) compared with sex-matched pairs. We conclude that the risks and benefits of sex-mismatched transplants appear to differ according to conditioning strategy and this could affect donor selection. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Year:  2015        PMID: 26250581      PMCID: PMC4825314          DOI: 10.3324/haematol.2015.125294

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  37 in total

1.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

Authors:  Madan Jagasia; Mukta Arora; Mary E D Flowers; Nelson J Chao; Philip L McCarthy; Corey S Cutler; Alvaro Urbano-Ispizua; Steven Z Pavletic; Michael D Haagenson; Mei-Jie Zhang; Joseph H Antin; Brian J Bolwell; Christopher Bredeson; Jean-Yves Cahn; Mitchell Cairo; Robert Peter Gale; Vikas Gupta; Stephanie J Lee; Mark Litzow; Daniel J Weisdorf; Mary M Horowitz; Theresa Hahn
Journal:  Blood       Date:  2011-10-18       Impact factor: 22.113

2.  Partial and total monosomal karyotypes in myelodysplastic syndromes: comparative prognostic relevance among 421 patients.

Authors:  Carolina B Belli; Raquel Bengió; Pedro Negri Aranguren; Francisco Sakamoto; María G Flores; Nora Watman; Elsa Nucifora; María V Prates; Jorge Arbelbide; Irene Larripa
Journal:  Am J Hematol       Date:  2011-06-14       Impact factor: 10.047

Review 3.  Myelodysplastic syndrome: review of the cytogenetic and molecular data.

Authors:  P Mhawech; A Saleem
Journal:  Crit Rev Oncol Hematol       Date:  2001-12       Impact factor: 6.312

4.  The negative impact of female donor/male recipient combination in allogeneic hematopoietic stem cell transplantation depends on disease risk.

Authors:  Yasuhito Nannya; Keisuke Kataoka; Akira Hangaishi; Yoichi Imai; Tsuyoshi Takahashi; Mineo Kurokawa
Journal:  Transpl Int       Date:  2011-02-05       Impact factor: 3.782

5.  Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients.

Authors:  Ahmet H Elmaagacli; Nina K Steckel; Michael Koldehoff; Yael Hegerfeldt; Rudolf Trenschel; Markus Ditschkowski; Sandra Christoph; Tanja Gromke; Lambros Kordelas; Hellmut D Ottinger; Rudolf S Ross; Peter A Horn; Susanne Schnittger; Dietrich W Beelen
Journal:  Blood       Date:  2011-05-03       Impact factor: 22.113

6.  Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies.

Authors:  Giuseppe Messina; Luisa Giaccone; Moreno Festuccia; Giuseppe Irrera; Ilaria Scortechini; Roberto Sorasio; Federica Gigli; Roberto Passera; Irene Cavattoni; Andrea Riccardo Filippi; Fabrizio Carnevale Schianca; Massimo Pini; Antonio M Risitano; Carmine Selleri; Alessandro Levis; Nicola Mordini; Andrea Gallamini; Rocco Pastano; Marco Casini; Massimo Aglietta; Mauro Montanari; Giuseppe Console; Mario Boccadoro; Umberto Ricardi; Benedetto Bruno
Journal:  Biol Blood Marrow Transplant       Date:  2012-04-05       Impact factor: 5.742

7.  H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease.

Authors:  Bita Sahaf; Yang Yang; Sally Arai; Leonard A Herzenberg; Leonore A Herzenberg; David B Miklos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 8.  Advances in predicting acute GVHD.

Authors:  Andrew C Harris; James L M Ferrara; John E Levine
Journal:  Br J Haematol       Date:  2012-12-04       Impact factor: 6.998

9.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

Review 10.  Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT.

Authors:  Edus H Warren; Xinyi Cindy Zhang; Shuying Li; Wenhong Fan; Barry E Storer; Jason W Chien; Michael J Boeckh; Lue Ping Zhao; Paul J Martin; John A Hansen
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

View more
  12 in total

1.  High-throughput allogeneic antibody detection using protein microarrays.

Authors:  Jed Paul; Bita Sahaf; Spenser Perloff; Kelsi Schoenrock; Fang Wu; Hideki Nakasone; John Coller; David Miklos
Journal:  J Immunol Methods       Date:  2016-02-20       Impact factor: 2.303

2.  BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient.

Authors:  Hideki Nakasone; Koji Kawamura; Kimikazu Yakushijin; Akihito Shinohara; Masatsugu Tanaka; Kazuteru Ohashi; Shuichi Ota; Naoyuki Uchida; Takahiro Fukuda; Hirohisa Nakamae; Ken-Ichi Matsuoka; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Yoshihiro Inamoto; Sachiko Seo; Fumihiko Kimura; Masao Ogata
Journal:  Blood Adv       Date:  2019-06-11

3.  Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia.

Authors:  Francesca Lorentino; Myriam Labopin; Fabio Ciceri; Luca Vago; Katharina Fleischhauer; Boris Afanasyev; Nicolaus Kröger; Jan J Cornelissen; Montserrat Lovira; Ellen Meijer; Antonin Vitek; Ahmet Elmaagacli; Didier Blaise; Annalisa Ruggeri; Christian Chabannon; Arnon Nagler; Mohamad Mohty
Journal:  Leukemia       Date:  2020-05-14       Impact factor: 11.528

4.  Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants.

Authors:  Y Wang; D-P Wu; Q-F Liu; L-P Xu; K-Y Liu; X-H Zhang; Y Xu; F Huang; X-J Huang
Journal:  Leukemia       Date:  2017-06-23       Impact factor: 11.528

5.  Donor Characteristics Predict the Success of Allogeneic Hematopoietic Stem Cell Transplantation in Thalassemia Major: A Single-Center Analysis of 250 Patients.

Authors:  Revathi Raj; Venkateswaran Vellaichamy Swaminathan; Satishkumar Meena; Harika Varla; Rumesh Chandar; Balasubramaniam Ramakrishnan; Mythyly Vaikuntham; Venkadadesikalu Maljetty; Ramya Uppuluri
Journal:  Indian J Hematol Blood Transfus       Date:  2021-09-07       Impact factor: 0.900

6.  Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant.

Authors:  Y Wang; H-X Wang; Y-R Lai; Z-M Sun; D-P Wu; M Jiang; D-H Liu; K-L Xu; Q-F Liu; L Liu; J-B Wang; F Gao; J Ou-Yang; S-J Gao; L-P Xu; X-J Huang
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528

7.  Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.

Authors:  Bronwen E Shaw; Brent R Logan; Stephen R Spellman; Steven G E Marsh; James Robinson; Joseph Pidala; Carolyn Hurley; Juliet Barker; Martin Maiers; Jason Dehn; Hailin Wang; Mike Haagenson; David Porter; Effie W Petersdorf; Ann Woolfrey; Mary M Horowitz; Michael Verneris; Katharine C Hsu; Katharina Fleischhauer; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-14       Impact factor: 5.742

8.  Stem cell transplantation during cancer.

Authors:  Xiao-Ying Zhang; Pei-Ying Zhang
Journal:  Oncol Lett       Date:  2016-10-13       Impact factor: 2.967

9.  Early and Late Complications in Patients with Allogeneic Transplantation of Hematopoietic Stem Cell - Case Report.

Authors:  Ivana Trajkovska; Borce Georgievski; Lidija Cevreska; Andrijana Gacovski; Taner Hasan; Natasha Nedeska-Minova
Journal:  Open Access Maced J Med Sci       Date:  2017-05-09

Review 10.  Immunogenetics in stem cell donor registry work: The DKMS example (Part 2).

Authors:  Alexander H Schmidt; Jürgen Sauter; Daniel M Baier; Jessica Daiss; Andreas Keller; Anja Klussmeier; Thilo Mengling; Gabi Rall; Tobias Riethmüller; Gerhard Schöfl; Ute V Solloch; Tigran Torosian; David Means; Helen Kelly; Latha Jagannathan; Patrick Paul; Anette S Giani; Sabine Hildebrand; Stephan Schumacher; Jan Markert; Monika Füssel; Jan A Hofmann; Thomas Schäfer; Julia Pingel; Vinzenz Lange; Johannes Schetelig
Journal:  Int J Immunogenet       Date:  2020-02-07       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.